Recombinant Virus NA/Neuraminidase Protein (Baculovirus)，His

Neuraminidase (NA) is a crucial enzyme on the surface of influenza viruses, playing a significant role in the virus's lifecycle by facilitating the release of newly formed viral particles from infected cells and promoting viral spread. Its importance in the pathology of influenza has made NA a target for antiviral drugs, such as oseltamivir (Tamiflu) and zanamivir (Relenza), which inhibit its activity to reduce virus transmission. Furthermore, NA is also a key component in the development of influenza vaccines, particularly for its ability to elicit an immune response. Due to the frequent mutations in the NA gene, which can lead to variations in enzyme structure and function, continual surveillance and study of this protein are essential. The production of recombinant NA protein has gained traction as a valuable tool for research purposes. By utilizing techniques such as recombinant DNA technology, scientists can produce large quantities of pure NA for structural studies, functional assays, and vaccine development. This approach allows for a better understanding of the evolutionary dynamics of the virus and the immune response it elicits, providing insights into potential vaccine strategies and antiviral treatments. As influenza remains a significant global health challenge, ongoing research into NA recombinants aims to improve therapeutic options and guide public health responses to influenza outbreaks.